Social Appropriation of Knowledge and its contributions to the prevention of cutaneous leishmaniasis in rural contexts
IF 1.4
Q3 HEALTH CARE SCIENCES & SERVICES
Kathleen Agudelo Paipilla, D. Castro-Arroyave, Laura Guzmán Grajales, M. Echavarría
求助PDF
{"title":"Social Appropriation of Knowledge and its contributions to the prevention of cutaneous leishmaniasis in rural contexts","authors":"Kathleen Agudelo Paipilla, D. Castro-Arroyave, Laura Guzmán Grajales, M. Echavarría","doi":"10.1136/bmjinnov-2021-000899","DOIUrl":null,"url":null,"abstract":"© Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. BACKGROUND Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus, 2 typical of rural geographical territories, 4 and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 000 and 1 000 000 people a year around the world, mainly in the America s, the Mediterranean basin, the Middle East and Central Asia. Eighteen of the 21 countries that make up the Latin American (LA) region are considered endemic areas for this neglected tropical disease. Colombia is one of the countries that reports the majority of global cases with 6161 in 2020 and has the second highest number of cases in the Americas, after Brazil. 6 This disease is associated with poor socioeconomic conditions, low coverage of access to basic sanitation services and difficulties in accessing health services. Despite the various efforts of public health systems and leishmaniasis surveillance and control programmes, the implemented strategies are still challenged with being timely, efficient and sustainable. Additionally, barriers caused by geographical conditions and sociocultural aspects such as unawareness about the subject persist. 9 This scenario highlights the importance of proposing situated initiatives, based on the communities in favour of strengthening Social Appropriation of Knowledge (SAK) processes for the prevention and control of the disease.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"6 1","pages":"234 - 239"},"PeriodicalIF":1.4000,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjinnov-2021-000899","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 2
引用
批量引用
Abstract
© Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. BACKGROUND Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus, 2 typical of rural geographical territories, 4 and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 000 and 1 000 000 people a year around the world, mainly in the America s, the Mediterranean basin, the Middle East and Central Asia. Eighteen of the 21 countries that make up the Latin American (LA) region are considered endemic areas for this neglected tropical disease. Colombia is one of the countries that reports the majority of global cases with 6161 in 2020 and has the second highest number of cases in the Americas, after Brazil. 6 This disease is associated with poor socioeconomic conditions, low coverage of access to basic sanitation services and difficulties in accessing health services. Despite the various efforts of public health systems and leishmaniasis surveillance and control programmes, the implemented strategies are still challenged with being timely, efficient and sustainable. Additionally, barriers caused by geographical conditions and sociocultural aspects such as unawareness about the subject persist. 9 This scenario highlights the importance of proposing situated initiatives, based on the communities in favour of strengthening Social Appropriation of Knowledge (SAK) processes for the prevention and control of the disease.
知识的社会占有及其对预防农村皮肤利什曼病的贡献
©作者(或其雇主)2022。在CC BYNC下允许重用。禁止商业重用。请参阅权利和权限。英国医学杂志出版。背景皮肤利什曼病(CL)是一种被忽视的传染性地方病,通过Lutzomyia属媒介昆虫(白蛉)的叮咬传播,2在农村地理地区很典型,4并导致毁容的皮肤溃疡和残疾。据估计,全球每年有60万至100万人受到慢性阻塞性肺病的影响,主要分布在美洲、地中海盆地、中东和中亚。在构成拉丁美洲区域的21个国家中,有18个被认为是这种被忽视的热带病的流行地区。哥伦比亚是报告全球病例最多的国家之一,2020年有6161例病例,在美洲排名第二,仅次于巴西。6这种疾病与社会经济条件差、获得基本卫生服务的覆盖率低以及难以获得保健服务有关。尽管公共卫生系统和利什曼病监测和控制规划作出了各种努力,但实施的战略仍然面临着及时、有效和可持续的挑战。此外,地理条件和社会文化方面造成的障碍,如对这一主题的不了解,仍然存在。9 .这一设想突出了提出基于社区的就地倡议的重要性,这些倡议赞成加强社会利用知识的进程,以预防和控制这种疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
来源期刊
期刊介绍:
Healthcare is undergoing a revolution and novel medical technologies are being developed to treat patients in better and faster ways. Mobile revolution has put a handheld computer in pockets of billions and we are ushering in an era of mHealth. In developed and developing world alike healthcare costs are a concern and frugal innovations are being promoted for bringing down the costs of healthcare. BMJ Innovations aims to promote innovative research which creates new, cost-effective medical devices, technologies, processes and systems that improve patient care, with particular focus on the needs of patients, physicians, and the health care industry as a whole and act as a platform to catalyse and seed more innovations. Submissions to BMJ Innovations will be considered from all clinical areas of medicine along with business and process innovations that make healthcare accessible and affordable. Submissions from groups of investigators engaged in international collaborations are especially encouraged. The broad areas of innovations that this journal aims to chronicle include but are not limited to: Medical devices, mHealth and wearable health technologies, Assistive technologies, Diagnostics, Health IT, systems and process innovation.